Integra LifeSciences IART Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 51.9%+1.1pp | 50.9%-1.5pp | 52.3%-0.3pp | 52.6%-0.9pp | 53.5%-1.2pp | |
| Operating margin | -29.8%+1.8pp | -31.6%-2.3pp | -29.3%+1.6pp | -30.9%-31.4pp | 0.6%-1.2pp | |
| Net margin | -30.1%+1.4pp | -31.6%— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | -38.6%+1.3pp | -39.9%— | —— | —— | —— | |
| Return on invested capital | -16.4%+1.3pp | -17.6%-1.5pp | -16.1%+2.3pp | -18.5%-18.8pp | 0.3%-0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.4×+0.8× | 2.5×-0.6× | 3.1×+1.9× | 1.2×0.0× | 1.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 1.9×+0.1× | 1.8×0.0× | 1.9×0.0× | 1.8×+0.6× | 1.3×+0.1× | |
| Per Share | ||||||
| Book value per share | $13.55-0.5% | $13.61+0.7% | $13.52-0.2% | $13.54-32.1% | $19.93-0.7% | |
| Valuation | ||||||
| Market capitalization | $1.38B+53.4% | $967.42M-13.3% | $1.12B+21.0% | $922.44M-45.7% | $1.7B-3.0% | |
| Price / sales | 0.8×+0.3× | 0.6×-0.1× | 0.7×+0.1× | 0.6×-0.5× | 1×0.0× | |
| Price / book | 1.3×+0.7× | 0.9×-0.1× | 1.1×+0.2× | 0.9×-0.2× | 1.1×0.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Integra LifeSciences's profit margins?
- Integra LifeSciences (IART) runs a 51.9% gross margin and a -29.8% operating margin, with a -30.1% net margin.
- Where do Integra LifeSciences's ratios come from?
- Every ratio is computed from Integra LifeSciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
